Harri Sihto, Ph.D.

Chairman of the Board. Adjunct Professor of Cancer Biology, whose research focuses on rare cancers.

The Chairman of the Board, Dr. Harri Sihto (born 1976) is a founding member of the Company. He is a biochemist, who received his Ph.D. degree in 2012 and was awarded with title of Adjunct Professor of Cancer Biology in 2015 at the University of Helsinki, Finland. Dr. Sihto’s research has focused on molecular cancer research and rare cancers for 15 years producing dozens of scientific publications, which are cited over 2000 times. Dr. Sihto is responsible for the management of the company at present.